[
    [
        {
            "time": "2021-11-12",
            "original_text": "A股共发生154宗大宗交易成交35.12亿元（11月12日）",
            "features": {
                "keywords": [
                    "大宗交易",
                    "A股",
                    "成交额"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股共发生154宗大宗交易成交35.12亿元（11月12日）",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "智飞生物现3笔大宗交易 共成交64,250.00万元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物现3笔大宗交易 共成交64,250.00万元",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "医药关于疫苗行业跟踪点评：辉瑞BIONTECH中期数据乐观 关注疫苗和低温存储产业链机会",
            "features": {
                "keywords": [
                    "疫苗",
                    "辉瑞",
                    "BIONTECH",
                    "中期数据",
                    "产业链"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药关于疫苗行业跟踪点评：辉瑞BIONTECH中期数据乐观 关注疫苗和低温存储产业链机会",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "最新疫苗好消息，复星医药获临床试验注册审评受理，概念股及",
            "features": {
                "keywords": [
                    "疫苗",
                    "复星医药",
                    "临床试验",
                    "审评受理"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最新疫苗好消息，复星医药获临床试验注册审评受理，概念股及",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "全球技术和服务商思拓凡携手四家中国企业进博会签订大单",
            "features": {
                "keywords": [
                    "思拓凡",
                    "进博会",
                    "大单",
                    "技术合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "全球技术和服务商思拓凡携手四家中国企业进博会签订大单",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "医药生物行业重大事件快评：全球首个新冠疫苗中期分析显示保护力超90％",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "中期分析",
                    "保护力",
                    "医药生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业重大事件快评：全球首个新冠疫苗中期分析显示保护力超90％",
                "Correlation": 8,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "病毒防治概念股市集体拉升，复星医药、乐普医疗涨幅居前",
            "features": {
                "keywords": [
                    "病毒防治",
                    "复星医药",
                    "乐普医疗",
                    "涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "病毒防治概念股市集体拉升，复星医药、乐普医疗涨幅居前",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-12",
            "original_text": "医药生物行业11月月报暨三季报总结：三季报医药整体表现良好 当前时点重点关注Q3业绩超预期的疫苗、CXO、医疗服务、零售药店等板块",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "疫苗",
                    "CXO",
                    "医疗服务",
                    "零售药店"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业11月月报暨三季报总结：三季报医药整体表现良好 当前时点重点关注Q3业绩超预期的疫苗、CXO、医疗服务、零售药店等板块",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]